US drugmakers allegedly collude on generic price hikes
14 May 2019 | By European Pharmaceutical Review
A coalition of 43 attorneys general allege generic drug manufacturers colluded, overcharging US states and consumers billions.
List view / Grid view
Generics
Japanese pharma market set for strong growth in 2019
12 April 2019 | By European Pharmaceutical Review
The report, published from CPhI Japan 2019, highlights the country as the second fastest growing mature market for solid dose drugs.
ESMO drives EU-level action to tackle shortages of essential medicines
11 April 2019 | By European Pharmaceutical Review
Shortages of inexpensive, essential medicines: calling for tangible political commitments in the EU...
Big pharma blamed for skyrocketing US drug prices
10 April 2019 | By European Pharmaceutical Review
Executives blamed high drug prices on the drugmakers and their pursuit of profits...
Heart drugs free from carcinogens identified as recalls drag on
5 April 2019 | By European Pharmaceutical Review
The Food and Drug Administration has released a list of 40 drugs used to treat hypertension and heart failure that don’t contain any known carcinogens...
New generic valsartan approved to address shortages
14 March 2019 | By Nikki Withers (European Pharmaceutical Review)
The FDA has prioritised the review of this drug application after multiple recalls of generic valsartan products from several manufacturers...
Indian government plans to colour code generics
7 March 2019 | By European Pharmaceutical Review
Colour-coded generics might help consumers differentiate between generics and branded medicines...
EU measures in support of generic pharmaceuticals producers
21 February 2019 | By European Pharmaceutical Review
The EU is adopting new rules which should boost the competitiveness of EU producers of generic medicines and biosimilar products...
FDA grant to help increase generic drugs delivered intravaginally or by IUD
21 January 2019 | By Nikki Withers (European Pharmaceutical Review)
Of the 21 drugs designed for delivery directly to the female genital tract, only four have a cost-effective, generic equivalent...
Rising drug prices linked to older products, study finds
8 January 2019 | By Nikki Withers (European Pharmaceutical Review)
The rising costs of brand-name drugs is largely driven by inflation in the prices of widely used existing drugs, according to a study published in the January issue of Health Affairs...
Pharmaceutical glass packaging market to grow at 6% CAGR
5 October 2018 | By Mike Stones
North America dominates the global market for pharmaceutical glass packaging, due to the region’s technical innovation and strong demand for pharmaceutical products...
FDA approves first generic versions of Suboxone for opioid dependence
19 June 2018 | By European Pharmaceutical Review
The FDA has approved the first generic versions of Suboxone sublingual film for the treatment of opioid dependence...
Generic antiplatelet drugs are as effective as brand name counterpart
14 March 2018 | By European Pharmaceutical Review
A study in Canada has demonstrated that generic antiplatelet drugs appear to be as equally effective as a brand name drug for heart patients.
FDA approves Glatopa a generic option for relapsing forms of multiple sclerosis
14 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Sandoz has announced that the FDA has approved and launch of Glatopa as a fully-substitutable, AP-rated generic version of Copaxone for relapsing forms of MS...
Report identifies two-tier pharmaceuticals market
10 August 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
A report released has identified a two-tier manufacturing market and forecast increased acquisitions by Indian companies...
Follow: